Related references
Note: Only part of the references are listed.Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1
Matthew W. Parker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale
Sheila Harris et al.
PLOS ONE (2012)
Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
Kurt Ballmer-Hofer et al.
BLOOD (2011)
Tying the knot: The cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines
Shalini Iyer et al.
FEBS JOURNAL (2011)
Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis
Ying-Hua Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Stromal regulation of vessel stability by MMP14 and TGFβ
Nor E. Sounni et al.
DISEASE MODELS & MECHANISMS (2010)
Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action
Napoleone Ferrara
MOLECULAR BIOLOGY OF THE CELL (2010)
VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A
Raul Catena et al.
MOLECULAR CANCER (2010)
VEGF-A165b Is Cytoprotective and Antiangiogenic in the Retina
Anette L. Magnussen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Recombinant Human VEGF165b Inhibits Experimental Choroidal Neovascularization
Jing Hua et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
E. S. Rennel et al.
BRITISH JOURNAL OF CANCER (2009)
Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels
Marie-Astrid Herve et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis
Snigdha Banerjee et al.
BIOCHEMISTRY (2008)
Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity
Harukiyo Kawamura et al.
CANCER RESEARCH (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents
Pierre Mineur et al.
JOURNAL OF CELL BIOLOGY (2007)
Structural basis for ligand and heparin binding to neuropilin B domains
Craig W. Vander Kooi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth
Qi Pan et al.
CANCER CELL (2007)
Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1
Anna Starzec et al.
LIFE SCIENCES (2006)
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2
S. Cebe Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
The role of VEGF receptors in angiogenesis;: complex partnerships
S Cébe-Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF
WB Liu et al.
CYTOKINE (2005)
Vascular endothelial growth factor and diabetic retinopathy: Role of oxidative stress
RB Caldwell et al.
CURRENT DRUG TARGETS (2005)
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
S Lee et al.
JOURNAL OF CELL BIOLOGY (2005)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity
JS Penn et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor
YA Muller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
VEGF(165) mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF(165)-receptor binding
S Soker et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension
CA Lambert et al.
MATRIX BIOLOGY (2001)
Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121
GB Whitaker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
VPF/VEGF and the angiogenic response
HF Dvorak
SEMINARS IN PERINATOLOGY (2000)
Share Paper
